
Vu Le
Supervisory Patent Examiner (ID: 5409, Phone: (571)272-7332 , Office: P/2668 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2615, 2621, 2613, 4157, 2899, 2624, 2668, 2713 |
| Total Applications | 831 |
| Issued Applications | 649 |
| Pending Applications | 80 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19629693
[patent_doc_number] => 20240408142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => PREPARATION METHOD FOR CANINE WHOLE BLOOD HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/206091
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18206091
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/206091 | PREPARATION METHOD FOR CANINE WHOLE BLOOD HEMATOPOIETIC STEM CELLS | Jun 5, 2023 | Pending |
Array
(
[id] => 18771126
[patent_doc_number] => 20230365936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => GENERATION OF SECRETOME-CONTAINING COMPOSITIONS, AND METHODS OF USING AND ANALYZING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/319224
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319224
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319224 | GENERATION OF SECRETOME-CONTAINING COMPOSITIONS, AND METHODS OF USING AND ANALYZING THE SAME | May 16, 2023 | Pending |
Array
(
[id] => 18752435
[patent_doc_number] => 20230355681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => PREVENTION OF MENOPAUSE ASSOCIATED OSTEOPOROSIS BY INTRA-OVARIAN ADMINISTRATION OF REGENERATIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/311449
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311449
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311449 | PREVENTION OF MENOPAUSE ASSOCIATED OSTEOPOROSIS BY INTRA-OVARIAN ADMINISTRATION OF REGENERATIVE CELLS | May 2, 2023 | Abandoned |
Array
(
[id] => 18707572
[patent_doc_number] => 20230330149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/300210
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18300210
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/300210 | ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL | Apr 12, 2023 | Abandoned |
Array
(
[id] => 19140465
[patent_doc_number] => 20240139253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Post-Natal Transplantation Of Factor VIII-Expressing Cells For Treatment of Hemophilia
[patent_app_type] => utility
[patent_app_number] => 18/129398
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18129398
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/129398 | Post-Natal Transplantation Of Factor VIII-Expressing Cells For Treatment of Hemophilia | Mar 30, 2023 | Issued |
Array
(
[id] => 19001996
[patent_doc_number] => 20240066067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 18/129399
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18129399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/129399 | IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA | Mar 30, 2023 | Pending |
Array
(
[id] => 18691112
[patent_doc_number] => 20230321320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => GRAFT SCAFFOLD FOR CARTILAGE REPAIR AND PROCESS FOR MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 18/192682
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192682
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192682 | GRAFT SCAFFOLD FOR CARTILAGE REPAIR AND PROCESS FOR MAKING SAME | Mar 29, 2023 | Abandoned |
Array
(
[id] => 19032495
[patent_doc_number] => 20240082310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) MESENCHYMAL STEM CELLS FOR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/190783
[patent_app_country] => US
[patent_app_date] => 2023-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18190783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/190783 | BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) MESENCHYMAL STEM CELLS FOR THERAPEUTIC APPLICATIONS | Mar 26, 2023 | Abandoned |
Array
(
[id] => 18510020
[patent_doc_number] => 20230226115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => HUMAN FACILITATING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/124656
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18124656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/124656 | HUMAN FACILITATING CELLS | Mar 21, 2023 | Pending |
Array
(
[id] => 18647817
[patent_doc_number] => 20230293592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => TREATMENT OF ERECTILE DYSFUNCTION USING MESENCHYMAL STEM CELLS OF AMNIOTIC FLUID
[patent_app_type] => utility
[patent_app_number] => 18/187334
[patent_app_country] => US
[patent_app_date] => 2023-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187334
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/187334 | TREATMENT OF ERECTILE DYSFUNCTION USING MESENCHYMAL STEM CELLS OF AMNIOTIC FLUID | Mar 20, 2023 | Pending |
Array
(
[id] => 18806892
[patent_doc_number] => 20230381225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => METHODS FOR THE TREATMENT OF BETA-THALASSEMIA
[patent_app_type] => utility
[patent_app_number] => 18/123920
[patent_app_country] => US
[patent_app_date] => 2023-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18123920
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/123920 | METHODS FOR THE TREATMENT OF BETA-THALASSEMIA | Mar 19, 2023 | Pending |
Array
(
[id] => 18647823
[patent_doc_number] => 20230293598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => PREVENTION OF RADIATION EXPOSURE ASSOCIATED PATHOLOGY BY TREATMENT WITH UMBILICAL CORD DERIVED REGENERATIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/184403
[patent_app_country] => US
[patent_app_date] => 2023-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18184403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/184403 | PREVENTION OF RADIATION EXPOSURE ASSOCIATED PATHOLOGY BY TREATMENT WITH UMBILICAL CORD DERIVED REGENERATIVE CELLS | Mar 14, 2023 | Pending |
Array
(
[id] => 18647822
[patent_doc_number] => 20230293597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => CARDIAC STEM CELLS FOR CARDIAC REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/175154
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175154
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175154 | Cardiac stem cells for cardiac repair | Feb 26, 2023 | Issued |
Array
(
[id] => 18610999
[patent_doc_number] => 20230277729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Photobiomodulation (PBM) and Anti-Microbial Photo Disinfection Therapy (aPDT) of
Morula Stem Cells (MoSC) In-Vivo and In-Vitro
[patent_app_type] => utility
[patent_app_number] => 18/173026
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173026
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173026 | Photobiomodulation (PBM) and Anti-Microbial Photo Disinfection Therapy (aPDT) of Morula Stem Cells (MoSC) In-Vivo and In-Vitro | Feb 21, 2023 | Pending |
Array
(
[id] => 18709513
[patent_doc_number] => 20230332131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => PRODUCTION OF ANTIGEN-SPECIFIC T-CELLS
[patent_app_type] => utility
[patent_app_number] => 18/111975
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/111975 | PRODUCTION OF ANTIGEN-SPECIFIC T-CELLS | Feb 20, 2023 | Abandoned |
Array
(
[id] => 18469160
[patent_doc_number] => 20230203444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHOD OF CULTURING NK CELLS AND KITS CONTAINING MEDIUM ADDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/112095
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112095 | METHOD OF CULTURING NK CELLS AND KITS CONTAINING MEDIUM ADDITIONS | Feb 20, 2023 | Abandoned |
Array
(
[id] => 18860131
[patent_doc_number] => 20230414565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 18/110093
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18110093
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/110093 | COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES | Feb 14, 2023 | Abandoned |
Array
(
[id] => 18844859
[patent_doc_number] => 20230407263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => GENERATION OF A MESENCHYMAL STROMAL CELL BANK FROM THE POOLED MONONUCLEAR CELLS OF MULTIPLE BONE MARROW DONORS
[patent_app_type] => utility
[patent_app_number] => 18/104924
[patent_app_country] => US
[patent_app_date] => 2023-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104924
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104924 | Generation of a mesenchymal stromal cell bank from the pooled mononuclear cells of multiple bone marrow donors | Feb 1, 2023 | Issued |
Array
(
[id] => 19331401
[patent_doc_number] => 20240245831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => Development of decellularized bovine bone graft
[patent_app_type] => utility
[patent_app_number] => 18/098994
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098994
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/098994 | Development of decellularized bovine bone graft | Jan 18, 2023 | Pending |
Array
(
[id] => 19232168
[patent_doc_number] => 20240189359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => COMBINATION THERAPY COMPRISING A COMPOSITION OF MESENCHYMAL STROMAL CELLS AND HYALURONIC ACID FOR USE IN TREATMENT OF OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 18/147269
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147269
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147269 | COMBINATION THERAPY COMPRISING A COMPOSITION OF MESENCHYMAL STROMAL CELLS AND HYALURONIC ACID FOR USE IN TREATMENT OF OSTEOARTHRITIS | Dec 27, 2022 | Pending |